3,0
24 mar 2021
Dipendente attuale, più di 3 anni
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
Great product, great people, fast paced, challenging.
Svantaggi
With growth has come micromanaging and pharma culture which is why I am concerned about the direction we are going. Dexcom is becoming everything I hated and left years ago. Time will tell. Ashame if they ruin a good thing.